UnitedHealth Group Incorporated
UNH
NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $362.9B
$399.66
▲ +0.85%
P/E
25.70
Mkt Cap
$362.9B
52-Wk Range
$255.97–$461.62
52-Week Range
$255.97 - $461.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 29.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Vertically integrated model combining insurance, care delivery, data, and pharmacy for cost optimization and synergies
- Massive scale with millions of members providing negotiating power with providers and pharmaceutical manufacturers
- Advanced data analytics and AI capabilities through Optum Insight enabling predictive health management and operational efficiency
- Diversified revenue streams across insurance premiums, care services, technology solutions, and pharmacy reducing business concentration risk
- Established networks of healthcare providers and specialists creating switching costs and customer lock-in
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging U.S. population driving demand for Medicare Advantage and senior-focused health plans
Value
Fairly valued vs Managed Care & Health Insurance peers
Momentum
Strong
+6.0% over 3m
Quality
Stable
Excellent business quality
Dividend
Solid
2.24% yield
Smart-money signal
Who's buying UNH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 27, 2026
JUL 16, 2026
Reported EPS of $6.38 vs $4.94 consensus (+29.1% surprise). Revenue of $112.0B vs $110.8B expected (+1.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+29.1%
Revenue trend · last 8Q
—
+7%
+10%
+13%
+12%
+12%
+2%
+0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$100.8B
$100.8B
$109.6B
$111.6B
$113.2B
$113.2B
$111.7B
$112.0B
Margins · last 8Q
Gross
32.7%
Operating
7.1%
Profit
4.9%
Wall Street consensus
20 analysts · 85% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
85%
Hold
10%
Sell
5%
Median Price Target
—
Latest: Bernstein · Sep 2, 2026
vs Industry
How UNH stacks vs Medical - Healthcare Plans
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related